amfAR, The Foundation for AIDS Research, today announced the launch of “Countdown to a Cure for HIV/AIDS,” a research initiative aimed at finding a broadly applicable cure for HIV by 2020. With a goal of investing $100 million in HIV cure research over the next six years, “Countdown to a Cure” will officially kick off at amfAR’s annual New York Gala on February 5.
“A decade ago, curing HIV was thought by many, if not most, in the scientific community to be impossible,” said amfAR CEO Kevin Robert Frost. “But the science has advanced by leaps and bounds in recent years, to the extent that there is now widespread agreement among researchers that a cure for HIV is possible—and even probable.”
Since its founding nearly 30 years ago, amfAR has been at the forefront of HIV/AIDS research, and was the first organization to aggressively pursue cure-focused HIV research. In 2010, the Foundation launched the amfAR Research Consortium on HIV Eradication (ARCHE), which supports collaborative teams of scientists at leading research institutions around the world in a directed effort to explore potential strategies for eliminating HIV infection.
(via press release)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.